| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A comparative study of [68Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer
|
Xi, Yun
|
|
|
50 |
9 |
p. 2885-2898
|
article
|
| 2 |
A convolutional neural network with self-attention for fully automated metabolic tumor volume delineation of head and neck cancer in [18F]FDG PET/CT
|
Nikulin, Pavel
|
|
|
50 |
9 |
p. 2751-2766
|
article
|
| 3 |
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
|
Darcourt, Jacques
|
|
|
50 |
9 |
p. 2727-2735
|
article
|
| 4 |
A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients
|
Wit, Esther M. K.
|
|
|
50 |
9 |
p. 2861-2871
|
article
|
| 5 |
Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models
|
Song, Wenyu
|
|
|
50 |
9 |
p. 2591-2594
|
article
|
| 6 |
A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer
|
Delgado Bolton, Roberto C.
|
|
|
50 |
9 |
p. 2588-2590
|
article
|
| 7 |
Comparison of renal clearance of [18F]AlF-RESCA-HER2-BCH and [18F]AlF-NOTA-HER2-BCH in mice and breast cancer patients
|
Liu, Jiayue
|
|
|
50 |
9 |
p. 2775-2786
|
article
|
| 8 |
Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer
|
Rosar, Florian
|
|
|
50 |
9 |
p. 2899-2909
|
article
|
| 9 |
Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis
|
Bacour, Y. A. A.
|
|
|
50 |
9 |
p. 2647-2655
|
article
|
| 10 |
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression
|
Wen, Xuejun
|
|
|
50 |
9 |
p. 2846-2860
|
article
|
| 11 |
Dylan V. Miller and Monica P. Revelo. Diagnostic Pathology: Cardiovascular, 3rd Edition
|
Mansi, Luigi
|
|
|
50 |
9 |
p. 2571
|
article
|
| 12 |
European guidelines update on PSMA PET/CT for prostate cancer staging—snap back to reality
|
Gelardi, Fabrizia
|
|
|
50 |
9 |
p. 2572-2575
|
article
|
| 13 |
[18F]-FDG PET/CT is useful for early detection of Stewart-Treves syndrome, in patients with chronic lymphedema
|
Ichikawa, Ryota
|
|
|
50 |
9 |
p. 2916-2917
|
article
|
| 14 |
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
|
Zboralski, Dirk
|
|
|
50 |
9 |
p. 2621-2635
|
article
|
| 15 |
First-in-human CLDN18.2 functional diagnostic pet imaging of digestive system neoplasms enables whole-body target mapping and lesion detection
|
Wang, Shujing
|
|
|
50 |
9 |
p. 2802-2817
|
article
|
| 16 |
[68 Ga]Ga-DOTA-FAPI-04: Focus the lesion in [18F]F-FDG hidden by metformin
|
Wang, Qixin
|
|
|
50 |
9 |
p. 2914-2915
|
article
|
| 17 |
[68 Ga]Ga-DOTATATE PET/CT versus [68 Ga]Ga-Exendin-4 PET/CT in the evaluation of metastatic insulinoma
|
Guo, Wei
|
|
|
50 |
9 |
p. 2910-2911
|
article
|
| 18 |
Identification of isolated hepatic sarcoidosis with [18F]FDG and [68 Ga]Ga-FAPI PET/CT
|
Pang, Yizhen
|
|
|
50 |
9 |
p. 2918-2919
|
article
|
| 19 |
Imaging and photodynamic therapy of prostate cancer using a theranostic PSMA-targeting ligand
|
Derks, Yvonne H. W.
|
|
|
50 |
9 |
p. 2872-2884
|
article
|
| 20 |
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)
|
Kratochwil, Clemens
|
|
|
50 |
9 |
p. 2830-2845
|
article
|
| 21 |
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease
|
Chen, Charles D.
|
|
|
50 |
9 |
p. 2669-2682
|
article
|
| 22 |
Metabolic kinetic modeling of [11C]methionine based on total-body PET in multiple myeloma
|
Li, Jiajin
|
|
|
50 |
9 |
p. 2683-2691
|
article
|
| 23 |
Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy
|
Liu, Yu
|
|
|
50 |
9 |
p. 2636-2646
|
article
|
| 24 |
PET/CT scan without sedation: how to use total-body PET/CT to salvage child’s involuntary movement?
|
Li, Yongjiang
|
|
|
50 |
9 |
p. 2912-2913
|
article
|
| 25 |
PET imaging of PARP expression using 68Ga-labelled inhibitors
|
Wang, Xiangwei
|
|
|
50 |
9 |
p. 2606-2620
|
article
|
| 26 |
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
|
Giovanella, Luca
|
|
|
50 |
9 |
p. 2767-2774
|
article
|
| 27 |
Preclinical evaluation of a novel EGFR&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes
|
Liang, Mingzhu
|
|
|
50 |
9 |
p. 2787-2801
|
article
|
| 28 |
Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
|
Ayati, Narjess
|
|
|
50 |
9 |
p. 2715-2726
|
article
|
| 29 |
Present and future of target therapies and theranostics: Refining traditions and exploring new frontiers
|
Hertz, Barbara
|
|
|
50 |
9 |
p. 2605
|
article
|
| 30 |
Radioligand therapies in cancer: mapping the educational landscape in Europe
|
Bugani, Valentina
|
|
|
50 |
9 |
p. 2692-2698
|
article
|
| 31 |
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
|
Gabiña, Pablo Mínguez
|
|
|
50 |
9 |
p. 2595-2604
|
article
|
| 32 |
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors
|
Mapelli, Paola
|
|
|
50 |
9 |
p. 2818-2829
|
article
|
| 33 |
Superfluous, controversial and luxury issues in nuclear medicine
|
Ekmekcioglu, Ozgul
|
|
|
50 |
9 |
p. 2582-2587
|
article
|
| 34 |
The prognostic value of [18F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria
|
Sachpekidis, Christos
|
|
|
50 |
9 |
p. 2699-2714
|
article
|
| 35 |
The QuADRANT study: current status and recommendations for improving uptake and implementation of clinical audit of medical radiological procedures in Europe—the nuclear medicine perspective
|
Delgado Bolton, Roberto C.
|
|
|
50 |
9 |
p. 2576-2581
|
article
|
| 36 |
Towards in vivo characterization of thyroid nodules suspicious for malignancy using multispectral optoacoustic tomography
|
Noltes, Milou E.
|
|
|
50 |
9 |
p. 2736-2750
|
article
|
| 37 |
Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging
|
Williams, Michelle C.
|
|
|
50 |
9 |
p. 2656-2668
|
article
|
Journal description